BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36920103)

  • 1. Development of a Cyclic, Cell Penetrating Peptide Compatible with In Vitro Selection Strategies.
    Abrigo NA; Dods KK; Makovsky CA; Lohan S; Mitra K; Newcomb KM; Le A; Hartman MCT
    ACS Chem Biol; 2023 Apr; 18(4):746-755. PubMed ID: 36920103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a Cyclic Cell-Penetrating Peptide with Improved Endosomal Escape and Cytosolic Delivery Efficiency.
    Buyanova M; Sahni A; Yang R; Sarkar A; Salim H; Pei D
    Mol Pharm; 2022 May; 19(5):1378-1388. PubMed ID: 35405068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic Cell-Penetrating Peptides as Efficient Intracellular Drug Delivery Tools.
    Park SE; Sajid MI; Parang K; Tiwari RK
    Mol Pharm; 2019 Sep; 16(9):3727-3743. PubMed ID: 31329448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic Cell-Penetrating Peptides with Single Hydrophobic Groups.
    Song J; Qian Z; Sahni A; Chen K; Pei D
    Chembiochem; 2019 Aug; 20(16):2085-2088. PubMed ID: 31298779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Short Hydrophobic Cell-Penetrating Peptides for Cytosolic Peptide Delivery by Rational Design.
    Schmidt S; Adjobo-Hermans MJ; Kohze R; Enderle T; Brock R; Milletti F
    Bioconjug Chem; 2017 Feb; 28(2):382-389. PubMed ID: 27966361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing Cell-Permeable Macrocyclic Peptides.
    Appiah Kubi G; Dougherty PG; Pei D
    Methods Mol Biol; 2019; 2001():41-59. PubMed ID: 31134566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-Surface Interactions on Arginine-Rich Cell-Penetrating Peptides Allow for Multiplex Modes of Internalization.
    Futaki S; Nakase I
    Acc Chem Res; 2017 Oct; 50(10):2449-2456. PubMed ID: 28910080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore.
    Trofimenko E; Grasso G; Heulot M; Chevalier N; Deriu MA; Dubuis G; Arribat Y; Serulla M; Michel S; Vantomme G; Ory F; Dam LC; Puyal J; Amati F; Lüthi A; Danani A; Widmann C
    Elife; 2021 Oct; 10():. PubMed ID: 34713805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rational design of cell-penetrating peptides for application in delivery systems.
    Kang Z; Ding G; Meng Z; Meng Q
    Peptides; 2019 Nov; 121():170149. PubMed ID: 31491454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When cationic cell-penetrating peptides meet hydrocarbons to enhance in-cell cargo delivery.
    Di Pisa M; Chassaing G; Swiecicki JM
    J Pept Sci; 2015 May; 21(5):356-69. PubMed ID: 25787823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage Selection of Cyclic Peptides for Application in Research and Drug Development.
    Deyle K; Kong XD; Heinis C
    Acc Chem Res; 2017 Aug; 50(8):1866-1874. PubMed ID: 28719188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivalent dextran hybrids for efficient cytosolic delivery of biomolecular cargoes.
    Becker B; Englert S; Schneider H; Yanakieva D; Hofmann S; Dombrowsky C; Macarrón Palacios A; Bitsch S; Elter A; Meckel T; Kugler B; Schirmacher A; Avrutina O; Diederichsen U; Kolmar H
    J Pept Sci; 2021 Apr; 27(4):e3298. PubMed ID: 33458922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes.
    Jha D; Mishra R; Gottschalk S; Wiesmüller KH; Ugurbil K; Maier ME; Engelmann J
    Bioconjug Chem; 2011 Mar; 22(3):319-28. PubMed ID: 21319732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocytosis, intracellular traffic and fate of cell penetrating peptide based conjugates and nanoparticles.
    Cleal K; He L; Watson PD; Jones AT
    Curr Pharm Des; 2013; 19(16):2878-94. PubMed ID: 23140451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma membrane depolarization reveals endosomal escape incapacity of cell-penetrating peptides.
    Serulla M; Anees P; Hallaj A; Trofimenko E; Kalia T; Krishnan Y; Widmann C
    Eur J Pharm Biopharm; 2023 Mar; 184():116-124. PubMed ID: 36709921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-type specific penetrating peptides: therapeutic promises and challenges.
    Zahid M; Robbins PD
    Molecules; 2015 Jul; 20(7):13055-70. PubMed ID: 26205050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances in the research and application of cell penetrating peptides].
    Xie Y; Wang S; Yuan Q; Xie N
    Sheng Wu Gong Cheng Xue Bao; 2019 Jul; 35(7):1162-1173. PubMed ID: 31328473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing Cell-Permeable Peptide Therapeutics That Enter the Cell by Endocytosis.
    Pei D
    ACS Symp Ser Am Chem Soc; 2022; 1417():179-197. PubMed ID: 37621949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Hydrophobic Cell-Penetrating Stapled Peptides as Drug Carriers.
    Tsuchiya K; Horikoshi K; Fujita M; Hirano M; Miyamoto M; Yokoo H; Demizu Y
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Targeting Peptide : From Identification to Validation to Mechanism of Transduction.
    Feldman KS; Pavlou MP; Zahid M
    Methods Mol Biol; 2021; 2211():97-112. PubMed ID: 33336273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.